---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-004103"
form_type: "8-K"
ticker: "ONCY"
cik: "0001129928"
company_name: "ONCOLYTICS BIOTECH INC"
filed_at: "2026-01-15T23:59:59+00:00"
generated_at: "2026-05-16T10:04:24.081873+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Oncolytics shareholders OK continuance to BC and domestication to Nevada

## Summary
- Continuance from Alberta to British Columbia approved: 85.21% in favor.
- Domestication from British Columbia to Nevada approved: 86.98% in favor.
- 2026 Incentive Award Plan approved (76.77% in favor), conditional on completion of continuance and domestication.
- Company expects to complete continuance and domestication by end of Q1 2026.

## SEC filing metadata
- accession: 0001104659-26-004103
- form_type: 8-K
- ticker: ONCY
- cik: 0001129928
- company_name: ONCOLYTICS BIOTECH INC
- filed_at: 2026-01-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1129928/000110465926004103/0001104659-26-004103-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1129928/000110465926004103/tm263290d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-004103
- JSON: https://secwatch.observer/filing/0001104659-26-004103.json
- Plain text: https://secwatch.observer/filing/0001104659-26-004103.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.